| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcaree Peter F |
Sr.VP and CFO |
• – – |
2011-07-01 |
4 |
AS |
$8.10 |
$40,475 |
D/D |
(5,000) |
59,886 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-06-14 |
4 |
S |
$7.54 |
$142,587 |
D/D |
(18,902) |
420,212 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-06-13 |
4 |
S |
$7.56 |
$8,301 |
D/D |
(1,098) |
439,114 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-06-09 |
4 |
S |
$7.48 |
$74,800 |
D/D |
(10,000) |
440,212 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-06-08 |
4 |
S |
$7.18 |
$107,700 |
D/D |
(15,000) |
450,212 |
|
- |
|
| Comstock Allan L |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$31,500 |
D/D |
4,375 |
26,107 |
|
- |
|
| Billet Van |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$31,500 |
D/D |
4,375 |
25,107 |
|
- |
|
| Tunstall Kathryn |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$31,500 |
D/D |
4,375 |
25,107 |
|
- |
|
| Milligan David V |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$31,500 |
D/D |
4,375 |
25,107 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$31,500 |
D/D |
4,375 |
137,197 |
|
- |
|
| Bishop Robert C |
Director |
– • – |
2011-06-03 |
4 |
OE |
$7.20 |
$45,000 |
D/D |
6,250 |
26,814 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-06-01 |
4 |
S |
$7.18 |
$107,700 |
D/D |
(15,000) |
465,212 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-05-25 |
4 |
S |
$7.08 |
$106,200 |
D/D |
(15,000) |
480,212 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-04-04 |
4 |
A |
$6.80 |
$59,500 |
D/D |
8,750 |
640,587 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2011-04-01 |
4 |
AS |
$6.70 |
$33,490 |
D/D |
(5,000) |
64,886 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-04-01 |
4 |
AS |
$6.66 |
$33,306 |
D/D |
(5,000) |
66,104 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-03-07 |
4/A |
A |
$6.57 |
$65,700 |
D/D |
10,000 |
631,837 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-03-07 |
4 |
D |
$6.57 |
$0 |
D/D |
(0) |
631,837 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2011-03-07 |
4 |
D |
$6.57 |
$10,847 |
D/D |
(1,651) |
79,775 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-03-07 |
4 |
D |
$6.57 |
$9,658 |
D/D |
(1,470) |
498,242 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2011-03-07 |
4 |
D |
$6.57 |
$8,870 |
D/D |
(1,350) |
72,786 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2011-03-07 |
4 |
D |
$6.57 |
$9,389 |
D/D |
(1,429) |
126,279 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-03-07 |
4 |
D |
$6.57 |
$10,847 |
D/D |
(1,651) |
73,953 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-03-03 |
4/A |
A |
$6.76 |
$422,500 |
D/D |
62,500 |
621,837 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2011-03-03 |
4 |
D |
$6.76 |
$21,166 |
D/D |
(3,131) |
32,241 |
|
- |
|
291 Records found
|
|
Page 2 of 12 |
|
|
